{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:20:41Z","timestamp":1771629641404,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jnma.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T20:24:30Z","timestamp":1517516670000},"page":"504-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Beta-cell Function and Metabolic Clearance Rate of Glucose in Patients with Major Mental Health Disorders on Antipsychotic Drug Treatment"],"prefix":"10.1016","volume":"110","author":[{"given":"Kehinde Sola","family":"Akinlade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheu Kadiri","family":"Rahamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Olufolahan","family":"Lasebikan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnma.2018.01.003_bib1","unstructured":"De Meyts P. The insulin receptor and its signal transduction network. In: De Groot LJ, Chrousos G, Dungan K, et\u00a0al, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000\u20132016."},{"issue":"3","key":"10.1016\/j.jnma.2018.01.003_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/014107680009300313","article-title":"Insulin coma therapy in schizophrenia","volume":"93","author":"Jones","year":"2000","journal-title":"J\u00a0R Soc Med"},{"issue":"1","key":"10.1016\/j.jnma.2018.01.003_bib3","first-page":"E15","article-title":"Current approaches for assessing insulin sensitivity and resistance in\u00a0vivo: advantages, limitations, and appropriate usage","volume":"294","author":"Muniyappa","year":"2008","journal-title":"Am J PhysiolEndocrinolMetab"},{"issue":"7","key":"10.1016\/j.jnma.2018.01.003_bib4","first-page":"413","article-title":"Complex genetics of type 2 diabetes: thrifty genes and previously neutral polymorphisms","volume":"86","author":"Turner","year":"1993","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.jnma.2018.01.003_bib5","first-page":"152","article-title":"The metabolic syndrome in patients with severe mental illnesses","volume":"6","author":"Toalson","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.jnma.2018.01.003_bib6","article-title":"Atypical antipsychotics and insulin resistance in acute mental illness: a case series","volume":"13","author":"Brown","year":"2011","journal-title":"Prim Care Companion CNS Disord"},{"issue":"5","key":"10.1016\/j.jnma.2018.01.003_bib7","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.26.5.1462","article-title":"Effect of acute psychotic stress in nondiabetic subjects on beta-cell function and insulin sensitivity","volume":"26","author":"Shiloah","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jnma.2018.01.003_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/1110-1105.193014","article-title":"Metabolically healthy obesity and metabolic syndrome in Nigerian adults with major mental illness","volume":"37","author":"Akinlade","year":"2016","journal-title":"Egypt J Psychiatr"},{"issue":"5","key":"10.1016\/j.jnma.2018.01.003_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0306-9877(02)00244-X","article-title":"Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases","volume":"59","author":"Ramasubbu","year":"2002","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jnma.2018.01.003_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/clinchem\/40.2.288","article-title":"Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter","volume":"40","author":"Owens","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.jnma.2018.01.003_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000026615","article-title":"Cerebrospinal cytokine levels in patients with acute depression","volume":"40","author":"Levine","year":"1999","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jnma.2018.01.003_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0306-9877(89)90026-1","article-title":"Hyperinsulinemia; a mediator of decreased food intake and weight loss in anorexia nervosa and major depression","volume":"28","author":"Licinio-Paixao","year":"1989","journal-title":"Med Hypotheses"},{"issue":"Suppl. 27","key":"10.1016\/j.jnma.2018.01.003_bib13","first-page":"27","article-title":"Effects of atypical antipsychotics on weight and serum lipid levels","volume":"62","author":"Meyer","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jnma.2018.01.003_bib14","first-page":"104","article-title":"Level of insulin resistance in schizophrenia patients and its association with treatment with antipsychotics","volume":"1","author":"Ray","year":"2016","journal-title":"J\u00a0Neuropsychopharmacol Mental Health"},{"issue":"4","key":"10.1016\/j.jnma.2018.01.003_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archpsyc.59.4.337","article-title":"Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia","volume":"59","author":"Newcomer","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.jnma.2018.01.003_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00005053-197512000-00006","article-title":"Depressive symptoms and the glucose tolerance test and insulin tolerance test","volume":"161","author":"Heninger","year":"1975","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.jnma.2018.01.003_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12291-012-0292-x","article-title":"Assessment of insulin resistance and metabolic syndrome in drug naive patients of bipolar disorder","volume":"29","author":"Guha","year":"2014","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.jnma.2018.01.003_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10401230590932380","article-title":"Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications","volume":"17","author":"McIntyre","year":"2005","journal-title":"Ann Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.jnma.2018.01.003_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.114.152850","article-title":"Insulin resistance and outcome in bipolar disorder","volume":"206","author":"Calkin","year":"2015","journal-title":"Br J Psychiatry"},{"issue":"9","key":"10.1016\/j.jnma.2018.01.003_bib20","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.2337\/db13-0430","article-title":"Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease","volume":"62","author":"Teff","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jnma.2018.01.003_bib21","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2337\/diabetes.54.5.1552","article-title":"Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia","volume":"54","author":"Johnson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jnma.2018.01.003_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diabetes.50.2.385","article-title":"Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice","volume":"50","author":"Masaki","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jnma.2018.01.003_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/153537020222700309","article-title":"Hypothalamic histamine neurons activate lipolysis in rat adipose tissue","volume":"227","author":"Tsuda","year":"2002","journal-title":"ExpBiol Med (Maywood)"},{"key":"10.1016\/j.jnma.2018.01.003_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","article-title":"AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism","volume":"1","author":"Kahn","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.jnma.2018.01.003_bib25","first-page":"576","article-title":"30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice","volume":"29","author":"Coccurello","year":"2009","journal-title":"J\u00a0ClinPsychopharmacol"},{"issue":"3","key":"10.1016\/j.jnma.2018.01.003_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1590\/1516-4446-2012-1052","article-title":"Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics","volume":"35","author":"Volpato","year":"2013","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/j.jnma.2018.01.003_bib27","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders, Clinical Version (SCID-CV)","author":"First","year":"1996"},{"issue":"4","key":"10.1016\/j.jnma.2018.01.003_bib28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/diacare.24.4.796","article-title":"Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times","volume":"24","author":"Stumvoll","year":"2001","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jnma.2018.01.003_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gm300","article-title":"Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia","volume":"4","author":"Ore\u0161i\u010d","year":"2012","journal-title":"Genome Med"},{"issue":"1\u20133","key":"10.1016\/j.jnma.2018.01.003_bib30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejphar.2013.08.034","article-title":"Investigation of the metabolic effects of chronic clozapine treatment on CCK-1 receptor deficient Otsuka Long Evans Tokushima Fatty (OLETF) rats","volume":"718","author":"Heged\u0171s","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jnma.2018.01.003_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/j.2051-5545.2008.tb00154.x","article-title":"Side effects of atypical antipsychotics: a brief overview","volume":"7","author":"\u00dc\u00e7ok","year":"2008","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jnma.2018.01.003_bib32","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jnma.2018.01.003_bib33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v60n0602","article-title":"Novel antipsychotics: comparison of weight gain liabilities","volume":"60","author":"Wirshing","year":"1999","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"Suppl. 7","key":"10.1016\/j.jnma.2018.01.003_bib34","first-page":"22","article-title":"Antipsychotic-induced weight gain: a review of the literature","volume":"62","author":"Allison","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.jnma.2018.01.003_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/mp.2010.33","article-title":"Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis","volume":"16","author":"Albaugh","year":"2011","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.jnma.2018.01.003_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","article-title":"Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity","volume":"23","author":"Stumvoll","year":"2000","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jnma.2018.01.003_bib37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/diab.32.7.627","article-title":"Relationship between serum glucose level and the metabolic clearance rate of glucose in non-insulin-dependent diabetes mellitus","volume":"32","author":"Revers","year":"1983","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.jnma.2018.01.003_bib38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s001250050735","article-title":"Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance","volume":"40","author":"Del Prato","year":"1997","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jnma.2018.01.003_bib39","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2337\/dc12-1316","article-title":"Insulin clearance and the incidence of type 2 diabetes in hispanics and African Americans: the IRAS family study","volume":"36","author":"Lee","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jnma.2018.01.003_bib40","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2337\/diacare.26.5.1597","article-title":"Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes","volume":"26","author":"Lean","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jnma.2018.01.003_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2337\/dc07-1593","article-title":"Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range","volume":"31","author":"Jani","year":"2008","journal-title":"Diabetes Care"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968417300810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968417300810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:17:14Z","timestamp":1758435434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968417300810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0027968417300810"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2018.01.003","relation":{},"ISSN":["0027-9684"],"issn-type":[{"value":"0027-9684","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-cell Function and Metabolic Clearance Rate of Glucose in Patients with Major Mental Health Disorders on Antipsychotic Drug Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Medical Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}